# To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients

> **NCT00986882** · PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 183 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** SAF312A
- **DRUG:** Placebo
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT00986882
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2020-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00986882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00986882, "To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00986882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*